Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Anderson, Kenneth
Item TypeName
Academic Article Novel therapeutic approaches for multiple myeloma.
Academic Article Recombinant humanized anti-CD40 monoclonal antibody triggers autologous antibody-dependent cell-mediated cytotoxicity against multiple myeloma cells.
Academic Article Novel immunomodulatory therapies in the treatment of multiple myeloma.
Academic Article Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion.
Academic Article Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function.
Academic Article Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.
Academic Article Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Academic Article A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma.
Academic Article Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
Academic Article The role of immunomodulatory drugs in multiple myeloma.
Academic Article Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
Academic Article Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer.
Concept Immunotherapy, Adoptive
Concept Immunotherapy
Academic Article From the guest editor: the evolving treatment paradigm in multiple myeloma.
Academic Article Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.
Academic Article New strategies in the treatment of multiple myeloma.
Academic Article Decoding the pathophysiology and the genetics of multiple myeloma to identify new therapeutic targets.
Academic Article Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOß as a novel target for multiple myeloma.
Academic Article Multiple myeloma.
Academic Article Immunotherapy strategies in multiple myeloma.
Academic Article Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?
Academic Article Targeting B-cell maturation antigen in multiple myeloma.
Academic Article The Rapid Evolution of Novel Therapies in Multiple Myeloma.
Academic Article Vision Statement for Multiple Myeloma: Future Directions.
Academic Article The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
Academic Article Immune Therapies in Multiple Myeloma.
Academic Article Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma.
Academic Article Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era.
Academic Article Promise of Immune Therapies in Multiple Myeloma.
Academic Article Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
Academic Article Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy.
Academic Article B cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma.
Academic Article BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma.
Search Criteria
  • Immunotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.